Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buckle

Showing results (901-910 of 997) with videos related to

Pageof 100
Sort By:
BMC Palliative Care|September 5, 2022
Communication of palliative care needs in discharge letters from hospice providers to primary care: a multisite sequential explanatory mixed methods studyKatharine Weetman, Jeremy Dale, Sarah J Mitchell, et al.
Nature Communications|September 23, 2018
A tissue-specific self-interacting chromatin domain forms independently of enhancer-promoter interactionsJill M Brown, Nigel A Roberts, Bryony Graham, et al.
Lancet (London, England)|December 5, 2018
Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trialCaroline Hartley, Fiona Moultrie, Amy Hoskin, et al.
Science (New York, N.Y.)|May 27, 2006
A regulatory SNP causes a human genetic disease by creating a new transcriptional promoterMarco De Gobbi, Vip Viprakasit, Jim R Hughes, et al.
Haematologica|May 30, 2013
Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type IChristian Babbs, Nigel A Roberts, Luis Sanchez-Pulido, et al.
Nature Communications|July 2, 2026
CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nucleaseSanja Brolih, Hafiz Saqib Ali, Caroline Scott, et al.
Frontiers in Medicine|March 7, 2025
Defining the value proposition in diagnostic technology: challenges and opportunities for its understanding and development - a review with a multiperspective reflective analysisTayana Soukup, Bernarda Zamora-Talaya, Shayan Bahadori, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidasesSheena McGowan, Christine A Oellig, Woldeamanuel A Birru, et al.
Archives of Neurology|November 13, 2008
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scaleRohit Bakshi, Mohit Neema, Brian C Healy, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosisJames M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Pageof 100

Showing results (901-910 of 997) with videos related to

Sort By:
Pageof 100
BMC Palliative Care|September 5, 2022
Communication of palliative care needs in discharge letters from hospice providers to primary care: a multisite sequential explanatory mixed methods studyKatharine Weetman, Jeremy Dale, Sarah J Mitchell, et al.
Nature Communications|September 23, 2018
A tissue-specific self-interacting chromatin domain forms independently of enhancer-promoter interactionsJill M Brown, Nigel A Roberts, Bryony Graham, et al.
Lancet (London, England)|December 5, 2018
Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: randomised placebo-controlled trialCaroline Hartley, Fiona Moultrie, Amy Hoskin, et al.
Science (New York, N.Y.)|May 27, 2006
A regulatory SNP causes a human genetic disease by creating a new transcriptional promoterMarco De Gobbi, Vip Viprakasit, Jim R Hughes, et al.
Haematologica|May 30, 2013
Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type IChristian Babbs, Nigel A Roberts, Luis Sanchez-Pulido, et al.
Nature Communications|July 2, 2026
CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nucleaseSanja Brolih, Hafiz Saqib Ali, Caroline Scott, et al.
Frontiers in Medicine|March 7, 2025
Defining the value proposition in diagnostic technology: challenges and opportunities for its understanding and development - a review with a multiperspective reflective analysisTayana Soukup, Bernarda Zamora-Talaya, Shayan Bahadori, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidasesSheena McGowan, Christine A Oellig, Woldeamanuel A Birru, et al.
Archives of Neurology|November 13, 2008
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scaleRohit Bakshi, Mohit Neema, Brian C Healy, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosisJames M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Pageof 100